Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_27899
http://purl.obolibrary.org/obo/CHEBI_27899
|
|---|---|
| Preferred Name | cisplatin |
| Synonyms |
Platamine
Neoplatin
Briplatin
Platinol
cis-diamminedichloroplatinum
Randa
Cisplatin
H6Cl2N2Pt
cis-[PtCl2(NH3)2]
(SP-4-2)-diamminedichloridoplatinum
dichloroplatinumdiamine
cis-dichlorodiammineplatinum(II)
cis-platin
cisplatin
Peyrone's salt
cisplatinum
cis-diammineplatinum(II) dichloride
Cismaplat
cisplatino
Lederplatin
Cl2H4N2Pt
cis-DDP
cis-diamminedichloridoplatinum(II)
(SP-4-2)-diamminedichloroplatinum
cis-diamminedichloroplatinum(II)
Cl2H6N2Pt
cisplatine
Platinex
Peyrone's chloride
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | cisplatin
|
|---|---|
| label | cisplatin
|
| DBSynonym |
platinum ammine chloride
platinol-aq
cis-diamminedichloroplatinum
trans-ddp
cddp
platinol
cis-ddp
See more
See less
|
| ATCCode | L01XA01
|
| Definition | A platinum-containing anticancer drug that interacts with, and forms cross-links between, DNA and proteins. It is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary.
|
| altId |
CHEBI:3722
CHEBI:23314
|
| has effect |
See more
See less
|
| has pharmacological target | |
| induces | |
| inhibits | |
| type | |
| has role |
See more
See less
|
| InChIKey |
InChIKey=LXZZYRPGZAFOLE-UHFFFAOYSA-L
InChIKey=DQLATGHUWYMOKM-UHFFFAOYSA-L
|
| is metabolised by |
See more
See less
|
| AHFScode | 10:00.00
|
| Synonym |
Platamine
Neoplatin
Briplatin
Platinol
cis-diamminedichloroplatinum
Randa
Cisplatin
H6Cl2N2Pt
cis-[PtCl2(NH3)2]
(SP-4-2)-diamminedichloridoplatinum
dichloroplatinumdiamine
cis-dichlorodiammineplatinum(II)
cis-platin
cisplatin
Peyrone's salt
cisplatinum
cis-diammineplatinum(II) dichloride
Cismaplat
cisplatino
Lederplatin
Cl2H4N2Pt
cis-DDP
cis-diamminedichloridoplatinum(II)
(SP-4-2)-diamminedichloroplatinum
cis-diamminedichloroplatinum(II)
Cl2H6N2Pt
cisplatine
Platinex
Peyrone's chloride
See more
See less
|
| xref |
CiteXplore:10883661
KEGG DRUG:D00275
National Drug Code Directory:0015-3072-20
CiteXplore:18472761
Drugs Product Database (DPD):2126613
CiteXplore:23604226
Wikipedia:http://en.wikipedia.org/wiki/Cisplatin
MolBase:25
Patent:DE2329485
HMDB:HMDB14656
ChemSpider:389985
PharmGKB:PA449014
KEGG COMPOUND:C06911
PubChem Compound:441203
Gmelin:2519
CiteXplore:23651576
ChEBI:27899
PubChem Substance:46504561
CASRN:15663-27-1
CiteXplore:12537968
Reaxys:11324567
CiteXplore:12935404
RxList:http://www.rxlist.com/cgi/generic3/cisplatin.htm
CiteXplore:12831510
DrugBank:DB00515
CiteXplore:16327988
Patent:DE2318020
CiteXplore:23554447
MetaCyc:CPD0-1392
Drugs.com:http://www.drugs.com/cdi/cisplatin.html
See more
See less
|
| CASRN | 15663-27-1
|
| prefixIRI | obo2:CHEBI_27899
|
| is transported by |
See more
See less
|
| related with | |
| SMILES |
[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
N[Pt](N)(Cl)Cl
|
| may interact with |
See more
See less
|
| DBname | cisplatin
|
| InChI |
InChI=1S/2ClH.2H2N.Pt/h2*1H;2*1H2;/q;;2*-1;+4/p-2
InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
|
| DBBrand |
cismaplat
platinoxan
carboquone
briplatin
neoplatin
biocisplatinum
cisplatyl
platidiam
citoplationo
platamine
randa
abiplatin
plastin
lederplatin
cisplatine
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |